Remove tag patients-association
article thumbnail

bluebird bio wins back-to-back landmark FDA approvals for first-in-class gene therapies

Pharmaceutical Technology

Last month, Zynteglo (betibeglogene autotemcel), or beti-cel, was approved as a one-time potentially curative gene therapy for patients with beta-thalassaemia who require regular blood transfusions. These approvals represent crucial milestones for bluebird bio, the gene therapy field, and patients with rare genetic diseases.

FDA 115
article thumbnail

American health is in for a “world of hurt”

World of DTC Marketing

teaspoons of salt a day, which translates into 3,400 milligrams (mg) of sodium That’s 50% more than the government’s recommended 2,300 mg for the general public and more than twice the 1,500 mg recommended for all adults by the more-precautionary American Heart Association. According to STAT News “Americans consume an average of 1.5

Insurance 190
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

Despite their potential multi-million-dollar sticker price, if haemophilia treatments by BioMarin and CSL Behring prove durable, they could help patients save money compared to current treatments, experts note. The program was put on hold in December 2020 following a patient report, but this was lifted in April 2021. million price tag.

Safety 111
article thumbnail

Do healthcare mergers and acquisitions lead to better care for patients?

Clarify Health

Today’s healthcare providers are seeing significantly more patients than they did a decade ago – many of whom are often sicker and have more complex care needs. These patients have evolving and growing needs and expectations for the quality of care delivered and overall patient experience.

Leads 52
article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

Immuno-oncology (IO) agents have transformed the cancer therapeutics landscape, driving long-term remissions in a subset of patients who historically had limited options. Although a subset of patients derives long-term benefits from IO therapies, a high percentage of patients still fail to respond or develop resistance to IO therapy.

article thumbnail

Maximizing Dental Practice Efficiency and Attracting Patients: Software and Marketing Tips

Referral MD

Improved Collaboration : Collaboration among dental professionals is crucial for successful patient care. You can securely share patient information, X-rays, and treatment plans, ensuring a smooth transition and continuity of care. This streamlined approach enhances patient satisfaction and builds trust in your practice.

article thumbnail

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

Historically, the pharmaceutical industry has failed to meet the needs of this patient population. Most famously, the US passed its Orphan Drug Act in 1983, providing innovators with financial motivation to develop orphan drugs and meet the needs of these forgotten patients. Efforts have been made to change this.